Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer
Condition:   Hormone Receptor Positive HER-2 Negative Breast Cancer Intervention:   Sponsors:   University Hospital Tuebingen;   University Hospital Ulm;   University Hospital Freiburg Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials